These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36697374)

  • 1. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.
    Liu M; Zhang Z; Zhang W; Liu SM
    WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
    Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
    Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma.
    Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D
    J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma.
    Shetti D; Mallela VR; Ye W; Sharif M; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
    Crit Rev Oncol Hematol; 2024 Aug; 200():104391. PubMed ID: 38795877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection.
    Wang P; Song Q; Ren J; Zhang W; Wang Y; Zhou L; Wang D; Chen K; Jiang L; Zhang B; Chen W; Qu C; Zhao H; Jiao Y
    Sci Transl Med; 2022 Nov; 14(672):eabp8704. PubMed ID: 36417488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
    Jiang P; Chan KCA; Lo YMD
    J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma.
    Luo B; Ma F; Liu H; Hu J; Rao L; Liu C; Jiang Y; Kuangzeng S; Lin X; Wang C; Lei Y; Si Z; Chen G; Zhou N; Liang C; Jiang F; Liu F; Dai W; Liu W; Gao Y; Li Z; Li X; Zhou G; Li B; Zhang Z; Nian W; Luo L; Liu X
    BMC Med; 2022 Jan; 20(1):8. PubMed ID: 35027051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
    Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
    Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.
    Deng Z; Ji Y; Han B; Tan Z; Ren Y; Gao J; Chen N; Ma C; Zhang Y; Yao Y; Lu H; Huang H; Xu M; Chen L; Zheng L; Gu J; Xiong D; Zhao J; Gu J; Chen Z; Wang K
    Genome Med; 2023 Nov; 15(1):93. PubMed ID: 37936230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
    Jeepalyam S; Sheel A; Ejaz A; Miller E; Manne A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies.
    Gonçalves E; Gonçalves-Reis M; Pereira-Leal JB; Cardoso J
    Sci Rep; 2022 Jul; 12(1):11512. PubMed ID: 35798798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
    Zeng C; Stroup EK; Zhang Z; Chiu BC; Zhang W
    Cancer Commun (Lond); 2019 Mar; 39(1):12. PubMed ID: 30922396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
    Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
    Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
    Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
    ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsies for hepatocellular carcinoma.
    Su YH; Kim AK; Jain S
    Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.